The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists’ perspective

RAS gene mutational status represents an imperative predictive biomarker to be tested in the clinical management of metastatic colorectal adenocarcinoma. Even if it is one of the most studied biomarkers in the era of precision medicine, several pre-analytical and analytical factors may still impasse...

Descripción completa

Detalles Bibliográficos
Autores principales: Malapelle, Umberto, Angerilli, Valentina, Pepe, Francesco, Fontanini, Gabriella, Lonardi, Sara, Scartozzi, Mario, Memeo, Lorenzo, Pruneri, Gianfranco, Marchetti, Antonio, Perrone, Giuseppe, Fassan, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462993/
https://www.ncbi.nlm.nih.gov/pubmed/37314870
http://dx.doi.org/10.32074/1591-951X-895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462993/
https://www.ncbi.nlm.nih.gov/pubmed/37314870
http://dx.doi.org/10.32074/1591-951X-895

Ejemplares similares